Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

0
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Category

Show more Refine

For: Khripun AI, Starshinin AV, Antipova YO, Lysenko MA, Urozhaeva YV, Gavrilenko OF, Rusantsova NA, Tyazhelnikov AA, Tikhonovskaya EY, Okolot NV, Sokolova MV, Fomina DS, Simonova EN, Kruglova TS, Chernov AA, Zagrebneva AI. Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment. TERAPEVT ARKH 2022;94:668-674. [PMID: 36286967 DOI: 10.26442/00403660.2022.05.201676] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 06/16/2022] [Indexed: 12/23/2022]

For:	Khripun AI, Starshinin AV, Antipova YO, Lysenko MA, Urozhaeva YV, Gavrilenko OF, Rusantsova NA, Tyazhelnikov AA, Tikhonovskaya EY, Okolot NV, Sokolova MV, Fomina DS, Simonova EN, Kruglova TS, Chernov AA, Zagrebneva AI. Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment. TERAPEVT ARKH 2022;94:668-674. [PMID: 36286967 DOI: 10.26442/00403660.2022.05.201676] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 06/16/2022] [Indexed: 12/23/2022]

No articles found.

(The first 100,000 artilces are displayed in RCA.)